Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.54 - $1.41 $7,409 - $19,346
-13,721 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.4 - $5.15 $334 - $1,230
-239 Reduced 1.71%
13,721 $19,000
Q4 2021

Feb 14, 2022

SELL
$4.27 - $6.97 $1,678 - $2,739
-393 Reduced 2.74%
13,960 $72,000
Q3 2021

Nov 15, 2021

BUY
$5.31 - $8.25 $15,499 - $24,081
2,919 Added 25.53%
14,353 $85,000
Q2 2021

Aug 17, 2021

BUY
$6.81 - $9.23 $77,865 - $105,535
11,434 New
11,434 $92,000
Q2 2019

Aug 14, 2019

SELL
$17.79 - $22.88 $278,200 - $357,797
-15,638 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$11.76 - $22.15 $17,745 - $33,424
1,509 Added 10.68%
15,638 $329,000
Q4 2018

Feb 14, 2019

BUY
$10.42 - $21.94 $147,224 - $309,990
14,129 New
14,129 $162,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $179M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.